초록 ▼

An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-

An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user and produces a sensor signal which is representative of the user's condition. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, e.g., subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused with a bolus and to be removed from the basal delivery of the fluid.

대표청구항 ▼

What is claimed is: 1. A method of infusing insulin into a body of a user, the method comprising: delivering a basal amount of insulin to a body of a user at a predetermined basal rate; determining a bolus amount of insulin to be delivered to the body of the user, determining at least one state var

What is claimed is: 1. A method of infusing insulin into a body of a user, the method comprising: delivering a basal amount of insulin to a body of a user at a predetermined basal rate; determining a bolus amount of insulin to be delivered to the body of the user, determining at least one state variable; determining, based on the at least one state variable, an additional amount of insulin to be delivered to the body of the user with the bolus amount of insulin; infusing the determined bolus amount of insulin and the determined additional amount of insulin to the user; and reducing the basal rate by the additional amount of insulin delivered with the bolus amount of insulin. 2. The method according to claim 1, wherein the at least one state variable is selected from the group consisting of subcutaneous insulin concentration, plasma insulin concentration, and insulin effect. 3. The method according to claim 1, wherein the determining at least one state variable includes determining subcutaneous insulin concentration, plasma insulin concentration, and insulin effect. 4. The method according to claim 1, wherein the determining the additional amount of insulin is further based on at least one gain, wherein the at least one gain corresponds to one of the at least one state variables. 5. The method according to claim 1, further including obtaining a blood glucose concentration of the user. 6. The method according to claim 5, wherein the determining a bolus amount of insulin is based on the obtained blood glucose concentration of the user. 7. The method according to claim 5, wherein the determining a bolus amount of insulin includes: generating a controller input based on the blood glucose concentration; generating commands by a proportional plus, integral plus, derivative (PID) controller from the controller input; and determining, based on the commands from the PID controller, the bolus amount of insulin to be delivered to the body of the user. 8. The method according to claim 7, wherein the determining a bolus amount of insulin to be delivered to the body of the user is further based on at least one preset PID controller gain selected such that the commands generated by the PID controller cause insulin to be infused into the body of the user in response to a glucose concentration at a rate substantially equal to the rate that beta cells would release insulin in an individual with a healthy normally functioning pancreas. 9. The method according to claim 8, wherein the at least one preset controller gain is selected by a method that includes the step of measuring an insulin response of at least one individual with a healthy normally functioning pancreas and calculating the at least one controller gain that causes the commands to substantially match the insulin response of the at least one individual. 10. The method of claim 1, further including providing a prompt to indicate that the bolus amount of insulin has been determined and receiving an input to indicate that the bolus amount of insulin should be infused to the user. 11. The method of claim 1, further comprising repeating after a predetermined period of time the determining at least one state variable, determining an additional amount of insulin to be delivered, infusing the determined bolus amount of insulin and the determined additional amount of insulin to the user, and reducing the basal rate by the additional amount of insulin delivered with the bolus amount of insulin. 12. The method of claim 1, further including obtaining a blood glucose concentration of the user, wherein: (a) the determining a bolus amount of insulin includes: generating a controller input based on the blood glucose concentration; generating commands by a proportional plus, integral plus, derivative (PID) controller from the controller input; and determining, based on the commands from the PID controller, the bolus amount of insulin to be delivered to the body of the user; (b) the at least one state variable is selected from the group consisting of subcutaneous insulin concentration, plasma insulin concentration, and insulin effect; and (c) the determining the additional amount of insulin is further based on at least one gain corresponding to one of the at least one state variables.